Serum fatty acid chain length associates with prevalent symptomatic end-stage osteoarthritis, independent of BMI by Meessen, JMTA, Saberi-Hosnijeh, F, Bomer, N, den Hollander, W, van der Bom, JG, van Hilten, JA, van Spil, WE, So-Osman, C, Uitterlinden, AG, Kloppenburg, M, Nelissen, RGHH, van Duijn, CM, Slagboom, PE, van Meurs, JBJ, Meulenbelt, I

Higher thyrotropin leads to unfavorable lipid profile and somewhat higher cardiovascular disease risk: evidence from multi-cohort Mendelian randomization and metabolomic profiling. by van Vliet, NA, Bos, MM, Thesing, CS, Chaker, L, Pietzner, M, Houtman, E, Neville, MJ, Li-Gao, R, Trompet, S, Mustafa, R, Ahmadizar, F, Beekman, M, Bot, M, Budde, K, Christodoulides, C, Dehghan, A, Delles, C, Elliott, P, Evangelou, M, Gao, H, Ghanbari, M, van Herwaarden, AE, Ikram, MA, Jaeger, M, Jukema, JW, Karaman, I, Karpe, F, Kloppenburg, M, Meessen, JMTA, Meulenbelt, I, Milaneschi, Y, Mooijaart, SP, Mook-Kanamori, DO, Netea, MG, Netea-Maier, RT, Peeters, RP, Penninx, BWJH, Sattar, N, Slagboom, PE, Suchiman, HED, Völzke, H, Willems van Dijk, K, Noordam, R, van Heemst, D